Evaluation of the clinical significance of serum pentraxin-3 levels in patients with polycystic ovary syndrome

Background: Polycystic ovary syndrome (PCOS) is commonly associated with insulin resistance (IR), hyperinsulinemia, and dyslipidemia, which play a role in the development of endothelial dysfunction and promote the early onset of cardiovascular diseases. The aim of this study was to evaluate the clin...

Full description

Bibliographic Details
Main Authors: Fatih Yeşil, Köksal Deveci, Pervin Karli
Format: Article
Language:English
Published: IMR Press 2022-02-01
Series:Clinical and Experimental Obstetrics & Gynecology
Subjects:
Online Access:https://www.imrpress.com/journal/CEOG/49/2/10.31083/j.ceog4902038
_version_ 1818232064160301056
author Fatih Yeşil
Köksal Deveci
Pervin Karli
author_facet Fatih Yeşil
Köksal Deveci
Pervin Karli
author_sort Fatih Yeşil
collection DOAJ
description Background: Polycystic ovary syndrome (PCOS) is commonly associated with insulin resistance (IR), hyperinsulinemia, and dyslipidemia, which play a role in the development of endothelial dysfunction and promote the early onset of cardiovascular diseases. The aim of this study was to evaluate the clinical importance of pentraxin-3 levels in PCOS patients. Methods: Forty-five female patients diagnosed with PCOS according to the 2003 Rotterdam criteria and 42 healthy women were included in the study. All women studied were tested within 3 and 5 days of their menstrual cycle. Ultrasonographic evaluation of each patient was first conducted using the suprapubic method. Serum PTX-3, endothelin 1 (ET-1), vascular cell adhesion molecule 1 (VCAM-1), intercellular adhesion molecule 1 (ICAM-1), and nitric oxide levels were measured using the enzyme-linked immunosorbent assay method. Results: Pentraxine-3 (PTX-3) levels in the patient group were significantly lower than those in the control group (p < 0.05). PTX-3 levels in the group with hirsutism were significantly higher than those in the nonhirsutism group (p < 0.05). Homeostatic model assessment for IR (HOMA-IR) levels in the patient group were significantly higher than those in the control group (p < 0.01). A weak negative correlation was found between PTX-3 and HbA1c levels. The accuracy rate of the PTX-3 test in distinguishing patients and nonpatients was moderate with a 0.634 area-under-the-curve value. Conclusions: During the follow-up of patients with PCOS, a decrease in serum PTX-3 levels associated with hirsutism and IR may be observed.
first_indexed 2024-12-12T11:00:20Z
format Article
id doaj.art-39fced1f14c24a08a6bd8fa1953c856c
institution Directory Open Access Journal
issn 0390-6663
language English
last_indexed 2024-12-12T11:00:20Z
publishDate 2022-02-01
publisher IMR Press
record_format Article
series Clinical and Experimental Obstetrics & Gynecology
spelling doaj.art-39fced1f14c24a08a6bd8fa1953c856c2022-12-22T00:26:32ZengIMR PressClinical and Experimental Obstetrics & Gynecology0390-66632022-02-014923810.31083/j.ceog4902038S0390-6663(22)01687-6Evaluation of the clinical significance of serum pentraxin-3 levels in patients with polycystic ovary syndromeFatih Yeşil0Köksal Deveci1Pervin Karli2Department of Biochemistry, Gaziosmanpaşa University, Faculty of Medicine, 60250 Tokat, TurkeyDepartment of Biochemistry, Gaziosmanpaşa University, Faculty of Medicine, 60250 Tokat, TurkeyDepartment of Obstetrics and Gynecology, İstinye University Medical Park Hospital, 34250 Samsun, TurkeyBackground: Polycystic ovary syndrome (PCOS) is commonly associated with insulin resistance (IR), hyperinsulinemia, and dyslipidemia, which play a role in the development of endothelial dysfunction and promote the early onset of cardiovascular diseases. The aim of this study was to evaluate the clinical importance of pentraxin-3 levels in PCOS patients. Methods: Forty-five female patients diagnosed with PCOS according to the 2003 Rotterdam criteria and 42 healthy women were included in the study. All women studied were tested within 3 and 5 days of their menstrual cycle. Ultrasonographic evaluation of each patient was first conducted using the suprapubic method. Serum PTX-3, endothelin 1 (ET-1), vascular cell adhesion molecule 1 (VCAM-1), intercellular adhesion molecule 1 (ICAM-1), and nitric oxide levels were measured using the enzyme-linked immunosorbent assay method. Results: Pentraxine-3 (PTX-3) levels in the patient group were significantly lower than those in the control group (p < 0.05). PTX-3 levels in the group with hirsutism were significantly higher than those in the nonhirsutism group (p < 0.05). Homeostatic model assessment for IR (HOMA-IR) levels in the patient group were significantly higher than those in the control group (p < 0.01). A weak negative correlation was found between PTX-3 and HbA1c levels. The accuracy rate of the PTX-3 test in distinguishing patients and nonpatients was moderate with a 0.634 area-under-the-curve value. Conclusions: During the follow-up of patients with PCOS, a decrease in serum PTX-3 levels associated with hirsutism and IR may be observed.https://www.imrpress.com/journal/CEOG/49/2/10.31083/j.ceog4902038pcosendothelium dysfunctionpentraxin-3homa-ir
spellingShingle Fatih Yeşil
Köksal Deveci
Pervin Karli
Evaluation of the clinical significance of serum pentraxin-3 levels in patients with polycystic ovary syndrome
Clinical and Experimental Obstetrics & Gynecology
pcos
endothelium dysfunction
pentraxin-3
homa-ir
title Evaluation of the clinical significance of serum pentraxin-3 levels in patients with polycystic ovary syndrome
title_full Evaluation of the clinical significance of serum pentraxin-3 levels in patients with polycystic ovary syndrome
title_fullStr Evaluation of the clinical significance of serum pentraxin-3 levels in patients with polycystic ovary syndrome
title_full_unstemmed Evaluation of the clinical significance of serum pentraxin-3 levels in patients with polycystic ovary syndrome
title_short Evaluation of the clinical significance of serum pentraxin-3 levels in patients with polycystic ovary syndrome
title_sort evaluation of the clinical significance of serum pentraxin 3 levels in patients with polycystic ovary syndrome
topic pcos
endothelium dysfunction
pentraxin-3
homa-ir
url https://www.imrpress.com/journal/CEOG/49/2/10.31083/j.ceog4902038
work_keys_str_mv AT fatihyesil evaluationoftheclinicalsignificanceofserumpentraxin3levelsinpatientswithpolycysticovarysyndrome
AT koksaldeveci evaluationoftheclinicalsignificanceofserumpentraxin3levelsinpatientswithpolycysticovarysyndrome
AT pervinkarli evaluationoftheclinicalsignificanceofserumpentraxin3levelsinpatientswithpolycysticovarysyndrome